Authors:
Schink, JC
Weller, E
Harris, LS
Cella, D
Gerstner, J
Falkson, C
Wadler, S
Citation: Jc. Schink et al., Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: An Eastern Cooperative Oncology Group phase II study (E2E93), CANCER J, 7(2), 2001, pp. 155-164
Authors:
Schiller, JH
Adak, S
Cella, D
DeVore, RF
Johnson, DH
Citation: Jh. Schiller et al., Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593 - A phase III trial of the Eastern Cooperative Oncology Group, J CL ONCOL, 19(8), 2001, pp. 2114-2122
Authors:
Basen-Engquist, K
Bodurka-Bevers, D
Fitzgerad, MA
Webster, K
Cella, D
Hu, SH
Gershenson, DM
Citation: K. Basen-engquist et al., Reliability and validity of the functional assessment of cancer therapy-ovarian, J CL ONCOL, 19(6), 2001, pp. 1809-1817
Citation: D. Cella et al., Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors, J CL ONCOL, 19(14), 2001, pp. 3385-3391
Authors:
Cameron, CL
Cella, D
Herndon, JE
Kornblith, AB
Zuckerman, E
Henderson, E
Weiss, RB
Cooper, MR
Silver, RT
Leone, L
Canellos, GP
Peterson, BA
Holland, JC
Citation: Cl. Cameron et al., Persistent symptoms among survivors of Hodgkin's disease: An explanatory model based on classical conditioning, HEALTH PSYC, 20(1), 2001, pp. 71-75
Authors:
Sitia, G
Cella, D
De Mitri, MS
Novati, R
Foppa, CU
Perackis, K
Bianchi, C
Lazzarin, A
Morsica, G
Citation: G. Sitia et al., Evolution of the E2 region of hepatitis C virus in an infant infected by mother-to-infant transmission, J MED VIROL, 64(4), 2001, pp. 476-481
Authors:
Kiebert, G
Wait, S
Bernhard, J
Bezjak, A
Cella, D
Day, R
Houghton, J
Moinpour, C
Scott, C
Stephens, R
Citation: G. Kiebert et al., Practice and policy of measuring quality of life and health economics in cancer clinical trials: A survey among co-operative trial groups, QUAL LIFE R, 9(10), 2000, pp. 1073-1080
Authors:
Ribaudo, JM
Cella, D
Hahn, EA
Lloyd, SR
Tchekmedyian, NS
Von Roenn, J
Leslie, WT
Citation: Jm. Ribaudo et al., Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire, QUAL LIFE R, 9(10), 2000, pp. 1137-1146
Authors:
Mock, V
Atkinson, A
Barsevick, A
Cella, D
Cimprich, B
Cleeland, C
Donnelly, J
Eisenberger, MA
Escalante, C
Hinds, P
Jacobsen, PB
Kaldor, P
Knight, SJ
Peterman, A
Piper, BF
Rugo, H
Sabbatini, P
Stahl, C
Citation: V. Mock et al., NCCN Practice Guidelines for cancer-related fatigue, ONCOLOGY-NY, 14(11A), 2000, pp. 151-161
Authors:
Bonomi, P
Kim, KM
Fairclough, D
Cella, D
Kugler, J
Rowinsky, E
Jiroutek, M
Johnson, D
Citation: P. Bonomi et al., Comparison of survival and quality of life in advanced non-small-cell lungcancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an eastern cooperativeoncology group trial, J CL ONCOL, 18(3), 2000, pp. 623-631
Authors:
Motzer, RJ
Murphy, BA
Bacik, J
Schwartz, LH
Nanus, DM
Mariani, T
Loehrer, P
Wilding, G
Fairclough, DL
Cella, D
Mazumdar, M
Citation: Rj. Motzer et al., Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acidfor patients with advanced renal cell carcinoma, J CL ONCOL, 18(16), 2000, pp. 2972-2980
Citation: D. Cella et Ch. Chang, A discussion of item response theory and its applications in health statusassessment, MED CARE, 38(9), 2000, pp. 66-72
Authors:
Audrain, J
Rimer, B
Cella, D
Stefanek, M
Garber, J
Pennanen, M
Helzlsouer, K
Vogel, V
Lin, TH
Lerman, C
Citation: J. Audrain et al., The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients, PSYCHO-ONC, 8(3), 1999, pp. 220-229
Authors:
Fairclough, DL
Fetting, JH
Cella, D
Wonson, W
Moinpour, CM
Citation: Dl. Fairclough et al., Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy, QUAL LIFE R, 8(8), 1999, pp. 723-731
Authors:
Ward, WL
Hahn, EA
Mo, F
Hernandez, L
Tulsky, DS
Cella, D
Citation: Wl. Ward et al., Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument, QUAL LIFE R, 8(3), 1999, pp. 181-195
Authors:
Lent, L
Hahn, E
Eremenco, S
Webster, K
Cella, D
Citation: L. Lent et al., Using cross-cultural input to adapt the Functional Assessment of Chronic Illness Therapy (FACIT) scales, ACTA ONCOL, 38(6), 1999, pp. 695-702
Authors:
Fallowfield, LJ
Leaity, SK
Howell, A
Benson, S
Cella, D
Citation: Lj. Fallowfield et al., Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B, BREAST CANC, 55(2), 1999, pp. 189-199
Citation: D. Cella et Ka. Webster, Quality of life and treatment value in the management of hematologic malignancies, SEMIN ONCOL, 26(5), 1999, pp. 34-42
Authors:
Wenzel, LB
Fairclough, DL
Brady, MJ
Cella, D
Garrett, KM
Kluhsman, BC
Crane, LA
Marcus, AC
Citation: Lb. Wenzel et al., Age-related differences in the quality of life of breast carcinoma patients after treatment, CANCER, 86(9), 1999, pp. 1768-1774
Authors:
Marcus, AC
Garrett, KM
Cella, D
Wenzel, LB
Brady, MJ
Crane, LA
McClatchey, MW
Kluhsman, BC
Pate-Willig, M
Citation: Ac. Marcus et al., Telephone counseling of breast cancer patients after treatment: A description of a randomized clinical trial, PSYCHO-ONC, 7(6), 1998, pp. 470-482